Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research9/3/2026Positive
HSIC
Henry Schein IncNASDAQHEALTHCAREMEDICAL DISTRIBUTION
Key Statistics
Market Cap
$10.01B
P/E Ratio
26.18
EPS
$3.43
Beta
0.81
52W High
$92.18
52W Low
$61.95
50-Day MA
$87.43
200-Day MA
$79.08
Dividend Yield
—
Profit Margin
2.96%
Forward P/E
15.41
PEG Ratio
1.81
About Henry Schein Inc
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Fundamentals
| Revenue (TTM) | $13.60B |
| Gross Profit (TTM) | $4.26B |
| EBITDA | $1.08B |
| Operating Margin | 5.76% |
| Return on Equity | 8.85% |
| Return on Assets | 4.39% |
| Revenue/Share (TTM) | $116.77 |
| Book Value | $28.21 |
| Price-to-Book | 3.21 |
| Price-to-Sales (TTM) | 0.74 |
| EV/Revenue | 1.013 |
| EV/EBITDA | 13.65 |
| Quarterly Earnings Growth (YoY) | 17.10% |
| Quarterly Revenue Growth (YoY) | 6.70% |
| Shares Outstanding | $111.45M |
| Float | $91.42M |
| % Insiders | 0.84% |
| % Institutions | 111.80% |
Historical Volatility
HV 10-Day
17.25%
HV 20-Day
14.97%
HV 30-Day
16.73%
HV 60-Day
20.38%
HV Rank
3.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($98.19 target)
4
Strong Buy5
Buy7
Hold1
SellLatest News
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/3/2026Positive
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors?
Zacks Investment Research8/25/2026Positive
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/21/2026Positive
Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?
Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.
Zacks Investment Research8/19/2026Neutral
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
Zacks Investment Research8/18/2026Positive
Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research8/14/2026Positive
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/10/2026Positive
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research8/10/2026Positive
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research8/6/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HSIC and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026